Clinical Cancer Research Meeting Calendar Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tan, M.-H.
Right arrow Articles by Teh, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tan, M.-H.
Right arrow Articles by Teh, B. T.
Clinical Cancer Research Vol. 10, 6315S-6321S, September 15, 2004
© 2004 American Association for Cancer Research

Proceedings of the First International Conference

Gene Expression Profiling of Renal Cell Carcinoma

Min-Han Tan1,6, Craig G. Rogers3, Jeffrey T. Cooper4,7, Jonathon A. Ditlev1, Thomas J. Maatman4,7, Ximing Yang5, Kyle A. Furge2 and Bin Tean Teh1

1 Laboratory of Cancer Genetics, and 2 Bioinformatics Special Program, Van Andel Research Institute, Grand Rapids, Michigan; 3 The Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland; 4 Metropolitan Hospital, Grand Rapids, Michigan; 5 Division of Surgical Pathology, Northwestern University, Chicago, Illinois; 6 Department of Medicine, Alexandra Hospital, Republic of Singapore; and 7 Department of Urology, Michigan State University, Lansing, Michigan

Renal cell carcinoma (RCC) is a histologically diverse disease, with variable and often unpredictable clinical behavior. The prognosis worsens dramatically with the onset of clinical metastasis, and current regimens of systemic therapy yield only modest benefits for metastatic RCC. Gene expression profiling is a promising technique for refining the diagnosis and staging of RCC, as well as for highlighting potential therapeutic targets. We review the recent advances in expression profiling of RCC and discuss the clinical and biological insights obtained from these studies.




This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
P. B. Romesser, D. H. Perlman, D. V. Faller, C. E. Costello, M. E. McComb, and G. V. Denis
Development of a Malignancy-Associated Proteomic Signature for Diffuse Large B-Cell Lymphoma
Am. J. Pathol., July 1, 2009; 175(1): 25 - 35.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. D. Raman, N. P. Mongan, L. Liu, S. K. Tickoo, D. M. Nanus, D. S. Scherr, and L. J. Gudas
Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma
Carcinogenesis, March 1, 2006; 27(3): 499 - 507.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.